These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36260689)

  • 1. The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple
    Arendse LB; Murithi JM; Qahash T; Pasaje CFA; Godoy LC; Dey S; Gibhard L; Ghidelli-Disse S; Drewes G; Bantscheff M; Lafuente-Monasterio MJ; Fienberg S; Wambua L; Gachuhi S; Coertzen D; van der Watt M; Reader J; Aswat AS; Erlank E; Venter N; Mittal N; Luth MR; Ottilie S; Winzeler EA; Koekemoer LL; Birkholtz LM; Niles JC; Llinás M; Fidock DA; Chibale K
    Sci Transl Med; 2022 Oct; 14(667):eabo7219. PubMed ID: 36260689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity.
    Vanaerschot M; Murithi JM; Pasaje CFA; Ghidelli-Disse S; Dwomoh L; Bird M; Spottiswoode N; Mittal N; Arendse LB; Owen ES; Wicht KJ; Siciliano G; Bösche M; Yeo T; Kumar TRS; Mok S; Carpenter EF; Giddins MJ; Sanz O; Ottilie S; Alano P; Chibale K; Llinás M; Uhlemann AC; Delves M; Tobin AB; Doerig C; Winzeler EA; Lee MCS; Niles JC; Fidock DA
    Cell Chem Biol; 2020 Jul; 27(7):806-816.e8. PubMed ID: 32359426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Amidated 3,6-Diphenylated Imidazopyridazines with Potent Antiplasmodium Activity Are Dual Inhibitors of
    Cheuka PM; Centani L; Arendse LB; Fienberg S; Wambua L; Renga SS; Dziwornu GA; Kumar M; Lawrence N; Taylor D; Wittlin S; Coertzen D; Reader J; van der Watt M; Birkholtz LM; Chibale K
    ACS Infect Dis; 2021 Jan; 7(1):34-46. PubMed ID: 33319990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
    Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
    PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the SR protein-phosphorylating CLK kinases of Plasmodium falciparum impairs blood stage replication and malaria transmission.
    Kern S; Agarwal S; Huber K; Gehring AP; Strödke B; Wirth CC; Brügl T; Abodo LO; Dandekar T; Doerig C; Fischer R; Tobin AB; Alam MM; Bracher F; Pradel G
    PLoS One; 2014; 9(9):e105732. PubMed ID: 25188378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
    Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
    Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Epigenetic Inhibitors against Plasmodium falciparum Asexual and Sexual Blood Stages.
    Vanheer LN; Zhang H; Lin G; Kafsack BFC
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR kinase inhibition reduces tissue factor expression and growth of pancreatic neuroendocrine tumors.
    Lewis CS; Elnakat Thomas H; Orr-Asman MA; Green LC; Boody RE; Matiash K; Karve A; Hisada YM; Davis HW; Qi X; Mercer CA; Lucas FV; Aronow BJ; Mackman N; Versteeg HH; Bogdanov VY
    J Thromb Haemost; 2019 Jan; 17(1):169-182. PubMed ID: 30472780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies.
    Bonilla-Ramirez L; Rios A; Quiliano M; Ramirez-Calderon G; Beltrán-Hortelano I; Franetich JF; Corcuera L; Bordessoulles M; Vettorazzi A; López de Cerain A; Aldana I; Mazier D; Pabón A; Galiano S
    Eur J Med Chem; 2018 Oct; 158():68-81. PubMed ID: 30199706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast-Acting Small Molecules Targeting Malarial Aspartyl Proteases, Plasmepsins, Inhibit Malaria Infection at Multiple Life Stages.
    Singh S; Rajendran V; He J; Singh AK; Achieng AO; Vandana ; Pant A; Nasamu AS; Pandit M; Singh J; Quadiri A; Gupta N; Poonam ; Ghosh PC; Singh BK; Narayanan L; Kempaiah P; Chandra R; Dunn BM; Pandey KC; Goldberg DE; Singh AP; Rathi B
    ACS Infect Dis; 2019 Feb; 5(2):184-198. PubMed ID: 30554511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent Plasmodium falciparum gametocytocidal compounds identified by exploring the kinase inhibitor chemical space for dual active antimalarials.
    van der Watt ME; Reader J; Churchyard A; Nondaba SH; Lauterbach SB; Niemand J; Abayomi S; van Biljon RA; Connacher JI; van Wyk RDJ; Le Manach C; Paquet T; González Cabrera D; Brunschwig C; Theron A; Lozano-Arias S; Rodrigues JFI; Herreros E; Leroy D; Duffy J; Street LJ; Chibale K; Mancama D; Coetzer TL; Birkholtz LM
    J Antimicrob Chemother; 2018 May; 73(5):1279-1290. PubMed ID: 29420756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor.
    Diaz CA; Allocco J; Powles MA; Yeung L; Donald RG; Anderson JW; Liberator PA
    Mol Biochem Parasitol; 2006 Mar; 146(1):78-88. PubMed ID: 16325279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Dual-Stage Malaria Inhibitors with New Targets.
    Raphemot R; Lafuente-Monasterio MJ; Gamo-Benito FJ; Clardy J; Derbyshire ER
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1430-7. PubMed ID: 26666931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box.
    Reader J; van der Watt ME; Taylor D; Le Manach C; Mittal N; Ottilie S; Theron A; Moyo P; Erlank E; Nardini L; Venter N; Lauterbach S; Bezuidenhout B; Horatscheck A; van Heerden A; Spillman NJ; Cowell AN; Connacher J; Opperman D; Orchard LM; Llinás M; Istvan ES; Goldberg DE; Boyle GA; Calvo D; Mancama D; Coetzer TL; Winzeler EA; Duffy J; Koekemoer LL; Basarab G; Chibale K; Birkholtz LM
    Nat Commun; 2021 Jan; 12(1):269. PubMed ID: 33431834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum.
    Malmquist NA; Moss TA; Mecheri S; Scherf A; Fuchter MJ
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16708-13. PubMed ID: 23011794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressing the global antimalarial portfolio: finding drugs which target multiple Plasmodium life stages.
    Smith PW; Diagana TT; Yeung BK
    Parasitology; 2014 Jan; 141(1):66-76. PubMed ID: 23746048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL) Confer Multidrug Resistance.
    LaMonte G; Lim MY; Wree M; Reimer C; Nachon M; Corey V; Gedeck P; Plouffe D; Du A; Figueroa N; Yeung B; Bifani P; Winzeler EA
    mBio; 2016 Jul; 7(4):. PubMed ID: 27381290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Basis for Inhibitor Potency and Selectivity of
    Fienberg S; Eyermann CJ; Arendse LB; Basarab GS; McPhail JA; Burke JE; Chibale K
    ACS Infect Dis; 2020 Nov; 6(11):3048-3063. PubMed ID: 32966036
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro Multistage Malaria Transmission Blocking Activity of Selected Malaria Box Compounds.
    Malebo HM; D'Alessandro S; Ebstie YA; Sorè H; Tenoh Guedoung AR; Katani SJ; Parapini S; Taramelli D; Habluetzel A
    Drug Des Devel Ther; 2020; 14():1593-1607. PubMed ID: 32425505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarial efficacy of MMV390048, an inhibitor of
    Paquet T; Le Manach C; Cabrera DG; Younis Y; Henrich PP; Abraham TS; Lee MCS; Basak R; Ghidelli-Disse S; Lafuente-Monasterio MJ; Bantscheff M; Ruecker A; Blagborough AM; Zakutansky SE; Zeeman AM; White KL; Shackleford DM; Mannila J; Morizzi J; Scheurer C; Angulo-Barturen I; Martínez MS; Ferrer S; Sanz LM; Gamo FJ; Reader J; Botha M; Dechering KJ; Sauerwein RW; Tungtaeng A; Vanachayangkul P; Lim CS; Burrows J; Witty MJ; Marsh KC; Bodenreider C; Rochford R; Solapure SM; Jiménez-Díaz MB; Wittlin S; Charman SA; Donini C; Campo B; Birkholtz LM; Hanson KK; Drewes G; Kocken CHM; Delves MJ; Leroy D; Fidock DA; Waterson D; Street LJ; Chibale K
    Sci Transl Med; 2017 Apr; 9(387):. PubMed ID: 28446690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.